Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
Phase 2
Recruiting
- Conditions
- Hepatocellular CarcinomaSolid Tumor, Adult
- Registration Number
- NCT04770207
- Lead Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Inclusion Criteria:<br><br> - Solid advanced malignant tumors<br><br> - Age between18 and 99 years<br><br> - Life expectancy is greater than three months<br><br>Exclusion Criteria:<br><br> - Benign tumor<br><br> - Life expectancy is less than three months<br><br> - Serious medical comorbidity<br><br> - Others
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing safety and treatment efficacy on intra-tumor injection of DEB for advanced tumors
- Secondary Outcome Measures
Name Time Method